 |
 |
|
|
|
| Erlotinib hydrochloride |
 |
| 99% |
 |
| 183319-69-9 |
 |
Lung cancer
API |
 |
Erlotinib HCl [CAS:183319-69-9]
Intermediates:
2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride [CAS:183322-17-0]
6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone [CAS:179688-29-0]
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline [CAS:183322-18-1]
Usage:Lung cancer
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
